Who Paid My Doc
P3 Multiple Myeloma Frontline
Research payments
$349,692
Through program year 2021, $349,692 in research payments was reported against P3 Multiple Myeloma Frontline, across 109 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $7,105 | 4 |
| 2020 | Research | $32,718 | 11 |
| 2019 | Research | $309,869 | 94 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Noopur Raje Boston, MA Named on 7 payments
- Jerome Goldschmidt Christiansburg, VA Named on 5 payments
- Saad Jamshed Rochester, NY Named on 5 payments
- Frederic Kass Santa Barbara, CA Named on 4 payments
- Jessica Snider Springfield, MO Named on 4 payments
- Madhu Midathada Lincoln, NE Named on 4 payments
- Stephan Kendall Salt Lake City, UT Named on 4 payments
- Mehdi Moezi Fleming Island, FL Named on 3 payments
- Muhammad Raza Memphis, TN Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.